OSSTEC is a spinout of Imperial College founded in 2021. Its lead product, ASCENT™, is a cementless unicompartmental (partial) knee replacement system supported by the CLARITY™ surgical instrumentation set.
Rooted in over a decade of research, OSSTEC commercialise research into 3D-printed bone mimicking structures begun by Prof. Jonathan Jeffries (CTO) in 2013 and further developed by Dr. Max Munford (CEO) during his PhD.
OSSTEC is positioned at the intersection of three sector tailwinds: the structural shift from cemented to cementless joint replacement fixation; the underpenetrated but clinically superior partial-knee segment; and the rapid migration of knee procedures into outpatient settings, where surgical efficiency and consumable savings are crucial.
Dr Max Munford & Professor Jonathan Jeffers
Co-founders
Leadership Profile
Dr Max Munford (CEO & Co-founder) completed OSSTEC’s foundation work during his PhD at Imperial’s London Biomechanics Research Group, led by Prof Jeffers. Max is the author of 6 peer-reviewed publications, has received executive training from Imperial and Harvard Business School and holds several positions including Enterprise Fellow at the Royal Academy of Engineering and Chair of the Imperial Founders Roundtable.
Prof Jonathan Jeffers (CTO & Co-founder) has directly led multiple Class III orthopaedic implants through regulatory approval, including at Finsbury Orthopaedics (acquired by J&J for ~£65m) and has founded and advised companies that have signed distribution and acquisition agreements with two separate orthopaedic majors. He is Associate Dean for Enterprise and a Professor of Mechanical Engineering at Imperial College.